These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


448 related items for PubMed ID: 18773713

  • 1. The importance of routine QT interval measurement in rhythm interpretation.
    Hutton DM.
    Dynamics; 2008; 19(3):29-33. PubMed ID: 18773713
    [Abstract] [Full Text] [Related]

  • 2. Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
    Sommargren CE, Drew BJ.
    AACN Adv Crit Care; 2007; 18(3):285-93. PubMed ID: 18019519
    [Abstract] [Full Text] [Related]

  • 3. Recipe for Torsades de Pointes.
    Scheibly K, Tsiperfal A.
    Prog Cardiovasc Nurs; 2009 Mar; 24(1):39-41. PubMed ID: 19261144
    [No Abstract] [Full Text] [Related]

  • 4. Practice standards for ECG monitoring in hospital settings: executive summary and guide for implementation.
    Drew BJ, Funk M.
    Crit Care Nurs Clin North Am; 2006 Jun; 18(2):157-68, ix. PubMed ID: 16728301
    [Abstract] [Full Text] [Related]

  • 5. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
    Kawabata M, Hirao K, Takeshi S, Sakurai K, Inagaki H, Hachiya H, Isobe M.
    J Electrocardiol; 2008 Jun; 41(2):117-22. PubMed ID: 18328336
    [Abstract] [Full Text] [Related]

  • 6. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
    Ghosh S, Apte P, Maroz N, Broor A, Zeineh N, Khan IA.
    Int J Cardiol; 2009 Aug 14; 136(2):225-7. PubMed ID: 18617280
    [Abstract] [Full Text] [Related]

  • 7. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L, Kinori M, Kogan Y, Swartzon M, Shalev H, Guy D, Ferenidou F, Mashav N, Sadeh B, Atzmony L, Kliuk-Ben-Basat O, Steinvil A, Justo D.
    J Electrocardiol; 2009 Aug 14; 42(4):353-357.e1. PubMed ID: 19261294
    [Abstract] [Full Text] [Related]

  • 8. ST-segment monitoring.
    Crit Care Nurse; 2008 Aug 14; 28(4):70-2. PubMed ID: 18669709
    [No Abstract] [Full Text] [Related]

  • 9. A method for constructing and estimating the RR-memory of the QT-interval and its inclusion in a multivariate biomarker for torsades de pointes risk.
    Trost DC.
    J Biopharm Stat; 2008 Aug 14; 18(4):773-96. PubMed ID: 18607807
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T, Ruiz ME.
    Clin Infect Dis; 2007 Mar 15; 44(6):e67-8. PubMed ID: 17304444
    [Abstract] [Full Text] [Related]

  • 14. What is QT interval prolongation?
    Vorchheimer DA.
    J Fam Pract; 2005 Jun 15; Suppl():S4-7. PubMed ID: 15938992
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anaesthetists' knowledge of the QT interval in a teaching hospital.
    Marshall SD, Myles PS.
    Anaesth Intensive Care; 2005 Dec 15; 33(6):773-6. PubMed ID: 16398384
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S, Marte F, Di Bella G, Currò A, Coglitore S.
    Int J Cardiol; 2008 Nov 12; 130(2):e71-3. PubMed ID: 18255176
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.